We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.72B
AUM Growth
-$313M
(-6.2%)
Cap. Flow
-$247M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
13.35%
Holding
1,246
New
455
Increased
271
Reduced
328
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$32.6M |
| 2 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$31.7M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$28.2M |
| 4 |
Targa Resources
TRGP
|
+$25.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$50.8M |
| 2 |
Walt Disney
DIS
|
+$49.8M |
| 3 |
Accenture
ACN
|
+$41.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$35.4M |
| 5 |
Valero Energy
VLO
|
+$30.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 13.89% |
| 4 | Consumer Discretionary | 12.13% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRCP
926
DELISTED
Perceptron Inc
PRCP
| $246K | 0.01% |
+50,700
| New | +$300K |
|
|
ENZN
927
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
| $246K | 0.01% |
523,865
+50,157
| +11% | +$24.5K |
|
928
First Business Financial Services
FBIZ
$562M
| $244K | 0.01% |
+10,630
| New | +$237K |
|
|
MZTI
929
The Marzetti Company
MZTI
$2.94B
| $242K | 0.01% |
2,186
-40
| -2% | -$4.29K |
|
930
GoDaddy
GDDY
$12.3B
| $239K | 0.01% |
7,390
-325,186
| -98% | -$9.78M |
|
931
Oppenheimer Holdings
OPY
$1.17B
| $239K | 0.01% |
+15,154
| New | +$226K |
|
932
Progress Software
PRGS
$1.55B
| $239K | 0.01% |
9,929
-168,914
| -94% | -$4.15M |
|
|
MOBL
933
DELISTED
MobileIron, Inc.
MOBL
| $238K | 0.01% |
+52,725
| New | +$197K |
|
|
AKAO
934
DELISTED
Achaogen Inc
AKAO
| $236K | 0.01% |
85,472
+10,330
| +14% | +$40.2K |
|
935
Bloomin' Brands
BLMN
$680M
| $234K | 0.01% |
13,860
-5,190
| -27% | -$87.3K |
|
|
QUMU
936
DELISTED
Qumu Corp.
QUMU
| $232K | ﹤0.01% |
50,324
+33,126
| +193% | +$122K |
|
|
STML
937
DELISTED
Stemline Therapeutics, Inc.
STML
| $232K | ﹤0.01% |
+49,860
| New | +$244K |
|
|
OMN
938
DELISTED
OMNOVA Solutions Inc.
OMN
| $232K | ﹤0.01% |
41,700
-13,568
| -25% | -$72.6K |
|
|
LAYN
939
DELISTED
Layne Christensen Co
LAYN
| $232K | ﹤0.01% |
+32,300
| New | +$189K |
|
|
RP
940
DELISTED
RealPage, Inc.
RP
| $231K | ﹤0.01% |
11,100
-500
| -4% | -$9.91K |
|
|
GNMX
941
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $231K | ﹤0.01% |
+52,600
| New | +$216K |
|
|
IMN
942
DELISTED
Imation
IMN
| $231K | ﹤0.01% |
148,753
+135,324
| +1,008% | +$147K |
|
|
COHR
943
DELISTED
Coherent Inc
COHR
| $229K | ﹤0.01% |
+2,490
| New | +$192K |
|
944
Insight Enterprises
NSIT
$3.55B
| $228K | ﹤0.01% |
7,948
-53,809
| -87% | -$1.35M |
|
945
Douglas Emmett
DEI
$2.06B
| $226K | ﹤0.01% |
+7,520
| New | +$213K |
|
946
Ingredion
INGR
$6.38B
| $225K | ﹤0.01% |
+2,110
| New | +$210K |
|
947
Atmos Energy
ATO
$29.9B
| $224K | ﹤0.01% |
+3,020
| New | +$207K |
|
|
N
948
DELISTED
Netsuite Inc
N
| $224K | ﹤0.01% |
+3,270
| New | +$214K |
|
|
LGF
949
DELISTED
Lions Gate Entertainment
LGF
| $221K | ﹤0.01% |
+10,100
| New | +$241K |
|
950
AAR Corp
AIR
$5.15B
| $219K | ﹤0.01% |
9,400
+400
| +4% | +$8.66K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2016 Portfolio in Review
As of Q1 2016, Jacobs Levy Equity Management held 1,246 positions worth $4.72B, down 6.2% from $5.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management withdrew a net $247M in Q1 2016, closing 160 positions and reducing 328 holdings. Its most notable exit was Merck, an estimated $50.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Endo International plc worth $16.8M.
- Jacobs Levy Equity Management's largest Q1 2016 buy was Endo International plc: 596,209 shares worth $16.8M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2016, an estimated $32.6M increase.
- Jacobs Levy Equity Management's biggest Q1 2016 reduction was Walt Disney, cutting an estimated $49.8M.
- Jacobs Levy Equity Management fully exited Merck in Q1 2016, selling an estimated $50.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.72B portfolio in Q1 2016.
- Jacobs Levy Equity Management opened 455 new positions and closed 160 in Q1 2016.
- Jacobs Levy Equity Management's portfolio value fell 6.2% quarter-over-quarter to $4.72B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2016, filed 16 May 2016.